Results 291 to 300 of about 37,820 (304)

Non-eosinophilic cor ticosteroid unresponsive asthma

Lancet, The, 1999
Gerrit Woltmann, Andrew J Wardlaw, Christopher E Brightling   +2 more
exaly  

Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma

New England Journal of Medicine, 2014
Oliver N Keene, Steven W Yancey, Ian D Pavord   +2 more
exaly  

Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial

Lancet Respiratory Medicine,the, 2017
Frank C Albers, Linda M Nelsen, Jennifer L Trevor   +2 more
exaly  

Eosinophilic Inflammation in Asthma

New England Journal of Medicine, 1990
Jean Bousquet, Pascal Chanez, Per Venge
exaly  

Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study

Lancet, The
Brian D Kent
exaly   +2 more sources

Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies

Lancet Respiratory Medicine,the, 2016
Steven W Yancey, Necdet B Gunsoy, Oliver N Keene   +2 more
exaly  

Immunophenotype of airway eosinophils in severe eosinophilic asthma

Airway cell biology and immunopathology
Thomas Stoup, Arnaud Dendooven, Emilie Delaunay, Edouard Cuvillon, Stephane Esnault, Louison Jan, Xing Li, Victor Margelidon-Cozzolino, Jacques Trauet, Thibault Vanderhaegen, Guillaume Lefevre, Geoffrey Mortuaire, Cécile Chenivesse   +12 more
openaire   +1 more source

Long-term Safety and Clinical Benefit of Mepolizumab in Patients With the Most Severe Eosinophilic Asthma: The COSMEX Study

Clinical Therapeutics, 2019
Guy G Brusselle, Matthew Masoli, Frank C Albers   +2 more
exaly  

Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma

New England Journal of Medicine, 2009
Pranabashis Haldar, Christopher E Brightling, Sumit Gupta   +2 more
exaly  

Long-term Efficacy and Safety of Mepolizumab in Patients With Severe Eosinophilic Asthma: A Multi-center, Open-label, Phase IIIb Study

Clinical Therapeutics, 2016
Pascal Chanez, Richard Leigh, Steven W Yancey   +2 more
exaly